PharmaDeals Review
PharmaDeals Review
PharmaDeals® Review analyses specific deals and examines trends and developments within deal making in different technology and therapy areas.
It also assesses data from PharmaDeals Agreements and details product licensing openings from PharmaDeals Opportunities.
PharmaDeals Review offers 24 pages of in-depth commentary accessible via the web - giving a quick and easy way of reviewing competitive alliances and assessing their impact on your business.
PharmaDeals Review comprises:
- Extensive feature articles - providing detailed analysis on recent deals as well as individual companies' deal histories
- Deal Tracker - late-phase and recently launched products are explored from the perspective of the deals done to bring them through development, offering insight into the complex alliance history of individual drugs
- Analyst Opinion - experts provide in-depth views of recent deals, presenting commentary and opinion
- Company Profile - an outline of a company's business activities and their deal history
- Business Commentary - Dr Fintan Walton, PharmaVentures' CEO, comments on topical industry issues and how they impact on deal making
- Conferences - a guide to the industry's main events
PharmaDeals Review saves you time by providing you with an instant overview of the pharmaceutical and biotechnology market.
